These results demonstrate that the loss of p53 not only affects tumor development and the expression of an iron-poor liver cancer phenotype, but greatly impacts systemic iron metabolism, resulting in the development of severe systemic iron deficiency in female p53LKO mice. The gene discussed is TP53; the disease is liver cancer.